Targeted In Vivo Imaging of Microscopic Tumors with Ferritin‐based Nanoprobes Across Biological Barriers
- 14 February 2014
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 26 (16) , 2566-2571
Abstract
The avascular microscopic breast and brain tumors (<1–2 mm diameter) can be noninvasively detected by designing human heavy-chain ferritin (HFn)-based nanoparticles as molecular probes for near-infrared fluorescence and magnetic resonance imaging. The intravenously injected HFn-based nanoparticles (Cy5.5–HFn and M–HFn) can cross the endothelium, epithelium, and blood–brain barriers and be internalized into tumor cells.Keywords
This publication has 34 references indexed in Scilit:
- Ferritin Nanocages To Encapsulate and Deliver Photosensitizers for Efficient Photodynamic Therapy against CancerACS Nano, 2013
- A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticleNature Medicine, 2012
- Cancer Nanotheranostics: Improving Imaging and Therapy by Targeted Delivery Across Biological BarriersAdvanced Materials, 2011
- Human ferritin cages for imaging vascular macrophagesBiomaterials, 2011
- Chimeric Ferritin Nanocages for Multiple Function Loading and Multimodal ImagingNano Letters, 2011
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- Serum ferritin: Past, present and futureBiochimica et Biophysica Acta (BBA) - General Subjects, 2010
- Binding and uptake of H-ferritin are mediated by human transferrin receptor-1Proceedings of the National Academy of Sciences, 2010
- Molecular MRI for sensitive and specific detection of lung metastasesProceedings of the National Academy of Sciences, 2010
- The case for early detectionNature Reviews Cancer, 2003